Skip to main content

Desai Veeral's Form 4 filing

agilon health, inc. (AGL) · filed Jul 25, 2022

Accession no.
0001209191-22-043105
Filed
Jul 25, 2022
Trade date
Jul 21, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.19M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Desai VeeralCIK 0001855973Officer (Chief Strategy & Dev. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 21, 2022Common StockMOption exerciseAcquired+79,768$1.00+$79,768357,979Direct
Jul 21, 2022Common StockSSaleDisposed−79,768$27.50−$2,193,620278,211Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 21, 2022Common StockMOption exerciseDisposed−79,768$0.00$057,441Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)